A detailed history of Hardman Johnston Global Advisors LLC transactions in Becton Dickinson & CO stock. As of the latest transaction made, Hardman Johnston Global Advisors LLC holds 81,311 shares of BDX stock, worth $18.5 Million. This represents 0.8% of its overall portfolio holdings.

Number of Shares
81,311
Previous 92,236 11.84%
Holding current value
$18.5 Million
Previous $21.6 Million 9.06%
% of portfolio
0.8%
Previous 0.87%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

SELL
$221.47 - $242.41 $2.42 Million - $2.65 Million
-10,925 Reduced 11.84%
81,311 $19.6 Million
Q2 2024

Aug 14, 2024

SELL
$225.07 - $246.17 $643,700 - $704,046
-2,860 Reduced 3.01%
92,236 $21.6 Million
Q1 2024

May 06, 2024

SELL
$233.45 - $247.73 $497,715 - $528,160
-2,132 Reduced 2.19%
95,096 $23.5 Million
Q4 2023

Jan 29, 2024

SELL
$232.24 - $267.23 $362,294 - $416,878
-1,560 Reduced 1.58%
97,228 $23.7 Million
Q3 2023

Oct 20, 2023

SELL
$254.9 - $283.59 $389,997 - $433,892
-1,530 Reduced 1.53%
98,788 $25.5 Million
Q2 2023

Aug 11, 2023

SELL
$238.39 - $265.32 $588,823 - $655,340
-2,470 Reduced 2.4%
100,318 $26.5 Million
Q1 2023

May 05, 2023

SELL
$229.71 - $259.35 $300,920 - $339,748
-1,310 Reduced 1.26%
102,788 $25.4 Million
Q4 2022

Feb 03, 2023

SELL
$218.29 - $256.91 $397,287 - $467,576
-1,820 Reduced 1.72%
104,098 $26.5 Million
Q3 2022

Nov 02, 2022

SELL
$51.03 - $264.23 $17,809 - $92,216
-349 Reduced 0.33%
105,918 $23.6 Million
Q2 2022

Aug 02, 2022

SELL
$234.74 - $275.42 $26,995 - $31,673
-115 Reduced 0.11%
106,267 $26.2 Million
Q1 2022

May 12, 2022

SELL
$243.64 - $270.48 $25,582 - $28,400
-105 Reduced 0.1%
106,382 $28.3 Million
Q4 2021

Jan 26, 2022

SELL
$230.08 - $250.94 $665,391 - $725,718
-2,892 Reduced 2.64%
106,487 $26.8 Million
Q3 2021

Nov 12, 2021

SELL
$232.72 - $256.47 $53,525 - $58,988
-230 Reduced 0.21%
109,379 $26.9 Million
Q2 2021

Aug 09, 2021

SELL
$232.65 - $254.58 $1.27 Million - $1.39 Million
-5,453 Reduced 4.74%
109,609 $26.7 Million
Q1 2021

May 12, 2021

SELL
$232.09 - $256.88 $170,586 - $188,806
-735 Reduced 0.63%
115,062 $28 Million
Q4 2020

Feb 11, 2021

BUY
$221.92 - $245.94 $3.48 Million - $3.86 Million
15,686 Added 15.67%
115,797 $29 Million
Q3 2020

Nov 16, 2020

SELL
$215.77 - $276.76 $69,046 - $88,563
-320 Reduced 0.32%
100,111 $23.3 Million
Q2 2020

Jul 23, 2020

SELL
$219.9 - $263.41 $4.38 Million - $5.25 Million
-19,930 Reduced 16.56%
100,431 $24 Million
Q1 2020

May 04, 2020

SELL
$195.69 - $279.01 $8.3 Million - $11.8 Million
-42,410 Reduced 26.06%
120,361 $27.7 Million
Q4 2019

Feb 05, 2020

SELL
$236.45 - $266.82 $1.52 Million - $1.71 Million
-6,416 Reduced 3.79%
162,771 $44.3 Million
Q3 2019

Oct 30, 2019

SELL
$230.58 - $256.08 $724,021 - $804,091
-3,140 Reduced 1.82%
169,187 $42.8 Million
Q2 2019

Aug 05, 2019

SELL
$217.4 - $246.08 $1.86 Million - $2.1 Million
-8,550 Reduced 4.73%
172,327 $43.4 Million
Q1 2019

May 03, 2019

SELL
$206.05 - $248.17 $972,556 - $1.17 Million
-4,720 Reduced 2.54%
180,877 $45.2 Million
Q4 2018

Feb 06, 2019

BUY
$204.73 - $257.93 $5.85 Million - $7.37 Million
28,565 Added 18.19%
185,597 $41.8 Million
Q3 2018

Oct 18, 2018

SELL
$233.07 - $256.0 $722,517 - $793,600
-3,100 Reduced 1.94%
157,032 $41 Million
Q2 2018

Jul 18, 2018

SELL
$208.1 - $233.85 $3.41 Million - $3.84 Million
-16,400 Reduced 9.29%
160,132 $38.4 Million
Q1 2018

Apr 30, 2018

BUY
$205.46 - $240.27 $18.6 Million - $21.7 Million
90,450 Added 105.07%
176,532 $38.3 Million
Q4 2017

Jan 26, 2018

SELL
$189.0 - $222.64 $81,270 - $95,735
-430 Reduced 0.5%
86,082 $18.4 Million
Q3 2017

Oct 30, 2017

BUY
$186.89 - $198.9 $74,756 - $79,560
400 Added 0.46%
86,512 $17 Million
Q2 2017

Aug 14, 2017

BUY
N/A
86,112
86,112 $16.8 Million

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $65.1B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Hardman Johnston Global Advisors LLC Portfolio

Follow Hardman Johnston Global Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hardman Johnston Global Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hardman Johnston Global Advisors LLC with notifications on news.